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Background: Retrospective studies have shown that delayed high-normal serum calcium and detectable 
iPTH are independent variables positively influencing outcome of prolonged parathyroid failure after total 
thyroidectomy (TT). The aim of the present study was to examine prospectively the ability of these two 
variables to predict permanent hypoparathyroidism in patients under replacement therapy for postoperative 
hypocalcemia.
Methods: Prospective observational multicenter study of patients undergoing TT followed by postoperative 
parathyroid failure (serum calcium <8 mg/dL within 24 h and PTH <15 pg/mL 4 h after surgery). Serum 
calcium, vitamin D and iPTH were determined before thyroidectomy, 24 h after surgery, at 1 month and 
then periodically until recovery of the parathyroid function or permanent hypoparathyroidism was diagnosed 
after at least 1 year follow-up.
Results: Some 145 patients with postoperative hypocalcemia were investigated [s-Ca24h 7.5 (0.5) mg/dL].  
Hypocalcemia recovered within 30 days in 91 (63%) patients and 54 (37%) developed protracted 
hypoparathyroidism {iPTH 5.8 [4] pg/mL at 1 month}, of whom 32 recovered within 1 year and 22 developed 
permanent hypoparathyroidism. Protracted hypoparathyroidism was related to few parathyroid glands 
remaining in situ (PGRIS). Serum calcium concentration (mg/dL) at 1 postoperative month correlated 
positively with the rate of recovery (percent) from protracted hypoparathyroidism: <8.5 (20%); 8.5–9 (29%); 
9.1–9.5 (70%); 9.6–10 (89%); >10 (83%) (P=0.013). Serum iPTH at 1 month was also higher (7.3 vs. 3.7 pg/mL;  
P=0.002) in recovered protracted hypoparathyroidism. The combination of both variables predicts the 
likelihood of recovery of the parathyroid function with >90% accuracy. 
Conclusions: High-normal serum calcium and low but detectable iPTH concentrations at 1 month 
after TT were associated with better outcome of protracted hypoparathyroidism. A nomogram 
combining both variables may guide medical treatment and monitoring of post-thyroidectomy prolonged 
hypoparathyroidism.
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Introduction
Total thyroidectomy (TT) has become the operation of 
choice for most patients with thyroid cancer or bilateral 
benign disease. The increasing use of TT, however, has 
been associated with more patients developing and being 
treated for postoperative hypocalcemia, which is currently 
its most common adverse effect (1-5). Medical treatment of 
postoperative hypocalcemia consists in the administration 
of calcium salts and active vitamin D metabolites according 
to three different strategies: routine treatment, reactive 
treatment (only for patients developing symptoms) or 
preventive supplementation for patients with low PTH 
and/or serum calcium 24 h after surgery. We adhere to 
the latter (6,7) to avoid overtreatment of those patients 
with a normal postoperative parathyroid function and to 
prevent symptomatic hypocalcemia, often requiring hospital 
readmission.
There are no reliable immediate postoperative 
biochemical parameters that allow the identification of those 
patients with hypocalcemia that will develop protracted 
or permanent hypoparathyroidism; consequently acute 
postoperative parathyroid failure is medically treated until 
parathyroid function returns to normal and patients can be 
weaned off replacement therapy. Despite the lack of good 
evidence studies, a common medical strategy during this 
initial period of parathyroid insufficiency consists of keeping 
the serum calcium in the low-normal range to stimulate the 
parathyroid glands and to avoid hypercalcaemia (8). Previous 
retrospective studies, however, have shown that normal-
high serum calcium levels and detectable iPTH well after 
TT are associated with an increased likelihood of recovery 
from protracted hypoparathyroidism (9,10). Further analysis 
revealed that the number of parathyroid glands remaining 
in situ (PGRIS) after TT had a synergistic effect with serum 
calcium levels in improving the likelihood of parathyroid 
function recovery in cases where replacement therapy had to 
be continued for more than 1 month after TT (11). 
The cellular biology events leading either to the 
recovery of the functionality of the parathyroid glands or 
to permanent hypoparathyroidism are unknown. Typically, 
the parathyroid glands stop secreting PTH for a more 
or less prolonged period of time and then, most often, 
PTH serum concentration returns to normal. Although 
in most instances hypoparathyroidism resolves within 
6 months, time to recovery may exceed 1 year (12). We 
have hypothesized (10) that resting the failing parathyroid 
glands keeping the serum calcium in the high-normal 
range during the initial postoperative period may help to 
restore the parathyroid function (parathyroid splinting). To 
further investigate this hypothesis, the present study aimed 
at assessing prospectively the influence of serum calcium 
concentrations under replacement therapy on the recovery 
of parathyroid function, and, more specifically, the ability of 
delayed serum calcium and iPTH concentrations to predict 
permanent hypoparathyroidism after the first postoperative 
month.
Methods
A prospective longitudinal observational cohort multicenter 
study was performed during the years 2013–2014 on 
consecutive adult patients undergoing first-time TT 
(either for benign or malignant conditions) followed by 
parathyroid failure defined as a serum calcium <8 mg/dL at 
24 h and PTH <15 pg/mL at 4 h after surgery. Participant 
centers were Fundación Jiménez Díaz (Madrid), University 
of Padova, Jagiellonian University Medical College 
(Krakow) and Hospital del Mar (Barcelona). Patients 
were started on replacement treatment after parathyroid 
insufficiency was diagnosed and then discharged from 
hospital and followed for at least 1 year. Exclusion criteria 
were reoperations, completion thyroidectomies and 
associated parathyroidectomy for primary or secondary 
hyperparathyroidism.
The study was approved by the Institutional Review 
Board at each participating center. Signed consent was 
obtained from recruited patients at the time postoperative 
hypocalcemia was diagnosed.
Definitions
Protracted hypoparathyroidism was diagnosed if iPTH 
concentration was low (<15 pg/mL) or undetectable 
and medical treatment was still necessary 1 month after 
TT (6). Factors influencing prolonged parathyroid failure 
were investigated comparing patients who recovered the 
parathyroid function within 1 month with those needing 
more prolonged therapy. Permanent hypoparathyroidism 
was diagnosed in patients with subnormal iPTH serum 
levels (<15 pg/mL) and requiring medical treatment 
after at least 1-year follow-up. Complete recovery of 
the parathyroid function was diagnosed when patients 
could keep normal  serum calcium levels  without 
supplementa t ion  and  iPTH concentra t ion  were 
normalized.
S13Gland Surgery, Vol 6, Suppl 1 December 2017
© Gland Surgery. All rights reserved. Gland Surg 2017;6(Suppl 1):S11-S19gs.amegroups.com
Patients’ management
Patients were discharged on the first or second postoperative 
day under replacement treatment with calcium carbonate 
(2–4 g/day) and calcitriol (0.5–1.5 mcg/day) according to the 
current protocols at the participating units. Serum calcium, 
vitamin D and iPTH concentrations were determined 
preoperatively, 24 h after TT, at 1 week and 1 month, and 
then every 3 months until recovery or up to 1 year. Once 
the pathology report was available, the number of PGRIS 
was calculated using the formula: 4 − (parathyroid glands 
autografted + parathyroid glands found in the specimen). 
Patients were then classified as PGRIS 1, 2, 3 or 4 (11).
Statistical analysis
An anonymized database was created and exported to the 
SPSS statistics software version 22.0 (IBM, Armonk, NY, 
USA). The main analysis was focused on the influence 
of serum calcium concentrations at 1 postoperative 
month on the proportion of patients with protracted 
hypoparathyroidism developing permanent parathyroid 
failure. Rates of recovery/permanent failure were compared 
at different serum calcium concentration ranges using the 
exact Fisher’s test. For quantitative variables, the unpaired 
Student’s t-test was employed. Binomial logistic regression 
analysis with predictors selected by a forward stepwise 
procedure was used to assess the risk factors for permanent 
hypoparathyroidism. Data are presented as mean (SD). 
Statistical significance was set at P<0.05.
Results
Some 164 patients were initially recruited but 19 were 
not included in the final analysis (Figure 1). Thus, 145 
patients with postoperative hypocalcemia were investigated. 
Demographic and clinical characteristics of the cohort are 
shown in Table 1. Hypocalcemia recovered within 1 month 
in 91 patients (63%) and 54 patients (37%) developed 
protracted hypoparathyroidism of whom 32 recovered the 
parathyroid function and 22 were diagnosed of permanent 
hypoparathyroidism after at least 1-year follow-up. Factors 
associated with failure to recover the parathyroid function 
within 1 month are shown in Table 2, the most significant 
one being the number of PGRIS.
The clinical and metabolic profiles of patients with 
protracted hypoparathyroidism who did or did not recover 
the parathyroid function within 1 year are shown in Table 3. 
Those with a serum calcium concentration above 9 mg/dL at 
1 postoperative month had a 77% iPTH recovery rate whereas 
lower concentrations were associated with only a 26% chance 
of parathyroid function restortation (P<0.001). No association 
was found between preoperative vitamin D levels and the 
development of protracted or permanent hypoparathyroidism.
The number of patients with protracted hypoparathyroidism 
developing permanent hypoparathyroidism was calculated 
for each of five serum calcium concentration ranges 
1 month after surgery (Figure 2). There was a parallel 
increase in the serum calcium concentration and the rate 
of parathyroid function recovery. No correlation was 
found between serum calcium and iPTH in patients with 
detectable PTH at 1 month (r=−0.119) suggesting that 
calcium concentrations, at this time point, play no role 
in determining iPTH concentrations. In addition, there 
were no differences in the serum calcium concentration 
in patients with detectable or undetectable iPTH at 
1 month [9.2 (0.6) vs. 9.6 (1.1) mg/dL; P=0.105]. A 
164 TT patients assessed
s-Ca 24 h <8 mg/dL
iPTH 4 h <13 pg/mL
19 exclusions
5: not meeting criteria
4: protocol violation
10: lost to F-U
145 TT patients available for analysis
Normal iPTH
N=91
Protracted hypoparathyroidism
N=54
Permanent hypoparathyroidism
N=22
Normal iPTH
N=32
1-month follow-up
1-year follow-up
Figure 1 Flow chart of patients with parathyroid failure after total 
thyroidectomy (TT) included in the present study. F-U, follow-up.
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multivariate analysis was carried out to predict the 
final parathyroid status in patients with protracted 
hypoparathyroidism and two independent variables were 
identified: the iPTH and serum calcium concentrations 
determined at 1 postoperative month; these classified 
correctly the final parathyroid function of 94% of the 
patients. An orientative nomogram to calculate the 
likelihood of recovery of the parathyroid function based 
on the multivariate analysis is shown in Figure 3 where 
the probability of permanent hypoparathyroidism is 
displayed as the intersection value when a straight line is 
drawn between calcium and iPTH levels.
To clarify the risk factors for permanent parathyroid 
failure in the whole cohort, those patients developing 
permanent hypoparathyroidism were compared with those 
with a normal parathyroid function at the end of the study 
(Table 4). Lower values for postoperative biochemical 
parameters and fewer PGRIS in patients who ultimately 
developed permanent hypoparathyroidism, indicate a 
more severe intraoperative injury to the parathyroid glands 
in these cases. Pre and postoperative vitamin D serum 
levels were similar in both groups. Remarkably, iPTH 
concentrations at 1 month were below preoperative values 
{32 [16] vs. 53 [21] pg/mL; P<0.001} in patients recovering 
early from hypocalcemia, suggesting that despite the 
parathyroid function was restored they had lost a significant 
iPTH reserve. 
Discussion
Parathyroid failure after TT is a dynamic syndrome 
expanding from transient postoperative hypocalcemia that 
recovers within a month to permanent hypoparathyroidism 
requiring life-long medical replacement therapy. The main 
causes leading to acute postoperative fall of iPTH have 
been progressively elucidated, the most relevant being 
PGRIS resulting from both inadvertent parathyroidectomy 
and parathyroid autotransplantation (9-12,14-16). Other, 
probably less important or common variables are weight of 
the specimen, reoperation for bleeding, thyroidectomy for 
Graves’s disease and female sex (5). 
Two thirds of postoperative hypocalcemias resolve within 
the first weeks after thyroidectomy but the rest persist 
after 1 month and require prolonged medical treatment. 
At this moment in time, the baseline clinical variables lose 
significance and few PGRIS appears to be the main factor 
leading to protracted hypoparathyroidism (11,16). In other 
words, disease-related and pathology variables appear to 
lose relevance as parathyroid failure moves away from the 
immediate postoperative period.
Late (>1 month) recovery of the parathyroid function is a 
poorly understood phenomenon. Over 75–80% of patients 
with protracted hypoparathyroidism will eventually recover, 
but time to parathyroid function return is highly variable 
and controversial. The current clinical guidelines state that 
the diagnosis of permanent hypoparathyroidism should 
be made if replacement therapy is still needed 6 months 
(European) (17) or even 1 year (USA) (18) after surgery, and 
some anecdotal reports have been published of resolution 
of “permanent” hypoparathyroidism well beyond this time 
period (12). This implies that in some patients, viable 
parathyroid tissue remains in the neck for months but is not 
Table 1 Demographic and clinical characteristics of 145 patients 
with postoperative parathyroid failure alter total thyroidectomy
Characteristic N (SD or %)
Age (years) 50 [15]
Gender, n [%]
Male 23 [16]
Female 122 [84]
Benign/malignant 75/67
Preoperative serum calcium (mg/dL) 9.4 (0.4)
Preoperative iPTH 24 h (pg/mL) 52 [21]
Preoperative 25-OH-D3 (ng/mL) 24 [19]
Serum calcium 24 h after surgery (mg/dL) 7.5 (0.5)
iPTH 24 h after surgery (pg/mL) 5.5 (5.9)
Calcium dosage at discharge (g/24 h) 3.5 (1.6)
Calcitriol dosage at discharge (mcg/24 h) 0.66 (0.4)
Protracted hypoparathyroidism, n [%] 54 [37]
Permanent hypoparathyroidism, n [%] 22 [15]
N of parathyroid glands identified 2.9 (0.9)
N of autotransplanted glands 0.28 (0.5)
Inadvertent parathyroidectomy 0.5 (0.6)
PGRIS* categories, n [%]
1 8 [6]
2 61 [42]
3 39 [27]
4 37 [26]
*PGRIS, parathyroid glands remaining in situ.
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secreting PTH for unknown reasons. 
In the absence of a better hypothesis, it seems logical 
to attribute this long-term inactivity of the parathyroid 
glands to an ischemic injury at the time of surgery, probably 
resulting in partial necrosis of the glandular parenchyma. 
In previous retrospective reports, we found that a normal-
high serum calcium concentration was an independent good 
predictor of recovery of the parathyroid function (9,10). 
This has been confirmed in the present prospective study 
where patients with protracted hypoparathyroidism and a 
1-month serum calcium concentration in the high-normal 
range showed a threefold recovery rate compared to those 
with levels below 9 mg/dL. Since all these patients were 
on replacement therapy it may be that this beneficial effect 
may result from the absence of metabolic stress on the 
failing parathyroid glands. To overcome the criticism that 
protracted hypoparathyroidism may be induced spuriously 
by iPTH-suppressive doses of calcium and calcitriol, we 
investigated a possible correlation between iPTH and 
serum calcium at 1 month and found none. This, however, 
cannot be completely ruled out for the occasional patient 
with serum calcium above 10 mg/dL. 
We can only  speculate  on why serum calc ium 
concentrations at 1 month are significantly different 
between patients with protracted hypoparathyroidism 
who do or do not recover the parathyroid function. 
Table 2 Demographic and clinical characteristics of patients recovering or not the parathyroid function within 1 postoperative month
Characteristic
Protracted hypoparathyroidism
P value
Yes (n=54) No (n=91)
Age (years) 49 [15] 50 [14] 0.249*
Gender, n [%] 0.347
†
Male 11 [20] 12 [13]
Female 43 [80] 79 [87]
Benign/malignant 26/28 49/42 0.602
†
Weight of the specimen (g) 99 [109] 61 [50] 0.308**
Preoperative serum calcium (mg/dL) 9.4 (0.4) 9.5 (0.4) 0.395*
Preoperative iPTH (pg/mL) 50 [20] 54 [22] 0.260*
Preoperative 25-OH-D3 (ng/mL) 20 [9] 26 [22] 0.086*
Serum calcium 24 h after surgery (mg/dL) 7.3 (0.5) 7.6 (0.5) <0.001*
iPTH 24 h after surgery (pg/mL) 2.6 [4] 7.2 [6] 0.008*
Serum calcium 1 month (mg/dL) 9.4 (0.9) 9.2 (0.5) 0.140*
Calcium dosage >1 month (g/24 h) 3.1 (1.4) NA –
Calcitriol dosage >1 month (mcg/24 h) 0.6 (0.3) NA –
iPTH 1 month after surgery (pg/mL) 5.8 (4.4) 32 [16] <0.001*
25-OH-D3 1 month after surgery (ng/mL) 23 [11] 26 [18] 0.180*
1, 25-OH2-D3 1 month after surgery (pg/mL) 38 [14] 34 [13] 0.086
PGRIS categories, n [%] 0.001
†
1 7 [88] 1 [12]
2 28 [46] 33 [54]
3 8 [20] 31 [80]
4 11 [30] 26 [70]
*, two-tailed Student-Fisher t-test for unpaired data and equivalent variances; **, Mann-Whitney U test; 
†
, χ
2
 test. NA, not applicable since 
these patients had recovered the parathyroid function at 1 month; PGRIS, parathyroid glands remaining in situ.
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The serum calcitriol serum concentrations were slightly 
higher in patients who recovered suggesting some 
parathyroid splinting function of the replacement therapy 
in this group. A main limitation of the present study, 
however, is that calcium and calcitriol dosages were left 
at the discretion of the participating units and that in 
some patients’ calcitriol was administered in a single 
daily dose while others received it twice daily. This limits 
the interpretation of the serum calcitriol concentrations. 
N e v e r t h e l e s s ,  t h i s  i s  t h e  f i r s t  s t u d y  r e p o r t i n g 
calcitriol serum concentrations in the management of 
postoperative hypocalcemia and the data suggest that this 
drug is helpful in supporting the failing parathyroid and 
that it should be routinely added to calcium salts when 
treating acute postoperative parathyroid failure.
In patients recovering from hypocalcemia, the final 
iPTH concentrations were significantly lower than the 
Table 3 Demographic and clinical characteristics of 54 patients with protracted hypoparathyroidism who did or did not develop permanent 
hypoparathyroidism
Characteristic
Permanent hypoparathyroidism
P value
Yes (n=22) No (n=32)
Age (years) 48 [14] 53 [15] 0.240*
Gender, n [%] 0.493
†
Male 3 [27] 8 [73]
Female 19 [44] 24 [56]
Benign/malignant (n) 10/12 16/16 0.865
†
Identified parathyroid glands 2.6 (0.9) 2.7 [1] 0.942*
Preoperative serum calcium (mg/dL) 9.3 (0.4) 9.4 (0.3) 0.263*
Preoperative iPTH (pg/mL) 42 [19] 54 [20] 0.039*
Preoperative 25-OH-D3 (ng/mL) 19 [9] 21 [8] 0.364*
Serum calcium 24 h after surgery (mg/dL) 7.2 (0.6) 7.4 (0.5) 0.194*
iPTH 24 h after surgery (pg/mL) 2.2 (3.6) 3.0 (0.5) 0.474*
iPTH 1 week after surgery (pg/mL) 2.1 (3.4) 2.9 (0.4) 0.474*
iPTH 1 month after surgery (pg/mL) 3.7 (3.9) 7.3 (4.2) 0.002*
Serum calcium 1 month after surgery (mg/dL) 8.9 (0.5) 9.7 (0.9) 0.002*
1, 25-OH2-D3 1 month after surgery (pg/mL) 34 [9] 41 [17] 0.074*
PGRIS categories, n [%] 0.911
†
1–2 15 [68] 20 [63]
3–4 7 [32] 12 [37]
*, two-tailed Student-Fisher t-test for unpaired data and equivalent variances; 
†
, χ
2
 test. PGRIS, parathyroid glands remaining in situ.
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Figure 2 Relationship between serum calcium concentrations at 
1 month after total thyroidectomy and the probability of recovery 
from protracted hypoparathyroidism.
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Table 4 Demographic and clinical characteristics of 145 patients with postoperative hypocalcemia who did (n=22) or did not (n=123) develop 
permanent hypoparathyroidism 
Characteristic
Permanent hypoparathyroidism
P value
Yes (n=22) No (n=123)
Age (years) 48 [14] 50 [16] 0.500*
Gender, n [%] 0.493
†
Male 3 [27] 8 [73]
Female 19 [44] 24 [56]
Benign/malignant 10/11 16/16 0.865
†
Identified parathyroid glands (n) 2.6 (0.9) 3.1 (0.9) 0.051*
Weight of the specimen (g) 66 [58] 66 [65] 0.995*
Preoperative serum calcium (mg/dL) 9.3 (0.4) 9.4 (0.3) 0.162*
Preoperative iPTH (pg/mL) 43 [19] 54 [21] 0.024*
Preoperative 25-OH-D3 (ng/mL) 19 [9] 25 [20] 0.195*
Serum calcium 24 h after surgery (mg/dL) 7.2 (0.6) 7.6 (0.5) 0.001*
iPTH 24 h after surgery (pg/mL) 2.2 (3.6) 6 (6.0) 0.001*
Detectable iPTH 24 h after surgery (yes/no) 6/16 75/48 0.003*
Detectable iPTH 1 month after surgery (yes/no) 10/12 113/10 0.001*
iPTH 1 week after surgery (pg/mL) 2.1 (3.4) 12.7 [13] 0.001*
iPTH 1 month after surgery (pg/mL) 3.7 (3.9) 25.7 [18] 0.002*
Serum calcium 1 month after surgery (mg/dL) 8.9 (0.5) 9.3 (0.7) 0.013*
25-OH-D3 1 month after surgery (ng/mL) 23 [11] 25 [16] 0.556*
1, 25-OH2-D3 1 month after surgery (pg/mL) 34 [9] 36 [14] 0.484*
PGRIS categories, n [%] 0.036
†
1–2 15 [22] 54 [78]
3–4 7 [9] 69 [91]
*, two-tailed Student-Fisher t-test for unpaired data and equivalent variances; 
†
, χ
2
 test. PGRIS, parathyroid glands remaining in situ.
preoperative baseline values. A significant drop from 
baseline iPTH concentrations was observed even in 
patients recovering from hypocalcemia within the first 
postoperative week. Thus, even though most patients 
recover from parathyroid failure after TT, the secretory 
capacity of the parathyroid glands is left impaired. This 
is in agreement with the seminal 1965 contribution of 
Wade et al. (19) and other recent observations (16,20). 
This relationship between intraoperative surgical injury 
of the parathyroid glands and reduced iPTH reserve has 
been further confirmed in the study of Lang et al. (21) 
who found that after TT for benign disease, PGRIS was 
the major determinant of protracted hypoparathyroidism 
and that aggressive parathyroid identification resulted 
in more patients developing postoperative hypocalcemia 
and protracted hypoparathyroidism. Put together, these 
studies suggest that, in the absence of renal impairment 
or medication interfering with the parathyroid function, 
iPTH serum concentrations long after TT correlate 
with the amount of functioning (surviving) parathyroid 
parenchyma.
In summary, the present prospective study emphasizes 
the relevance of serum calcium concentration 1 month 
after TT as prognostic factor for the recovery of 
the parathyroid function in patients with protracted 
hypoparathyroidism. A sensible interpretation of this 
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finding is that, by providing a more aggressive medical 
replacement therapy (parathyroid splinting), the ischemic 
non-functional parathyroid glands have a better chance 
to regain their secretory capacity as they rest after 
surgery in an environment of normal-high serum calcium 
concentration. 
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